No Detail Found!

Sequential butylphthalide therapy combined with dual antiplatelet therapy in the treatment of acute cerebral infarction

Author(s)
Xuewen Wo Departments of Neurology,Binzhou People’s Hospital,Shandong, 256610, China.
Jinyan Han Departments of Neurology,Binzhou People’s Hospital,Shandong, 256610, China.
Jiajia Wang Departments of Neurology,Binzhou People’s Hospital,Shandong, 256610, China.
Xinmin Wang Departments of Neurology,Binzhou People’s Hospital, Shandong, 256610, China
Xiaoying Liu Departments of Neurology,Binzhou People’s Hospital, Shandong, 256610, China.
Zhonggong Wang Departments of Neurology,Binzhou People’s Hospital,Shandong, 256610, China.
Abstract
Objective: To observe the clinical efficacy of sequential butylphthalide therapy combined with dual antiplatelet therapy in the treatment of elderly patients with acute cerebral infarction (ACI). Methods: One hundred and twenty-two elderly patients with ACI who were admitted to the department of neurology of our hospital at May 2016-August 2018 were selected grouped into a control group and an observation group by random number table method, 61 in each group. On the basis of conventional treatment, the patients in the control group were given dual antiplatelet therapy (aspirin enteric-coated tablets + clopidogrel bisulfate tablets), while the patients in the observation group were given sequential butylphthalide therapy on the basis of the control group. The clinical effects of the two groups were compared after four weeks of treatment, and the changes of National Institutes of Health Stroke Scale (NIHSS), ADL score, plasma 3-mercaptopyruvate sulphurtransferase (3-MST) and Amyloid ß42 (Aß42) levels and the occurrence of adverse reactions during treatment were recorded. Results: The clinical efficacy of the observation group was better than that of the control group (P0.05). After treatment, the NIHSS and ADL scores of the observation group were better than those of the control group (P0.05). The level of plasma 3-MST in the observation group was higher than that in the control group, and the level of plasma Aß42 was lower than that in the control group (P<0.05). No serious adverse reactions occurred during the treatment period in both groups. Conclusion: Butylphthalide sequential therapy combined with dual antiplatelet therapy is effective in the treatment of elderly ACI. It can effectively improve the plasma level of 3-MST and decrease the plasma level of Aß42, which is conducive to improving the living ability and neurological function of patients and has high safety.
Publication Details
Page(s) 615-620
DOI DOI not available
Published Journal: Pakistan Journal of Medical Sciences, Volume: 36, Issue: 4, Year: 2020

Request the full text from PASTIC

Keywords
Sequential therapy, Butylphthalide
0

Citations

0

Downloads

58

Views